US FDA approves GSK's H1N1 vaccine
This article was originally published in Scrip
Executive Summary
The US FDA has approved GlaxoSmithKline's unadjuvanted H1N1 vaccine for adults. The product was filed as a strain change supplement to GSK’s FluLaval seasonal flu vaccine, which was launched in the US in 2006.